1293740

Cadila Pharmaceuticals Limited — FEI 3007684569

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 26, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ahmedabad (India)

Additional Details

Postmarket Adverse Drug Experience (PADE)